New hope for tough cancers: testing powerful drug combos
Disease control
Recruiting now
This study is testing whether an immunotherapy drug (anti-PD-1) works better alone or when combined with other treatments for people whose cancers have returned or stopped responding to standard therapies. It will involve about 250 patients with various advanced cancers, includin…
Phase: PHASE1, PHASE2 • Sponsor: Han weidong • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC